Get started
Author

Won Sik Lee

Minimization of the Escherichia coli genome using a Tn5-targeted Cre/loxP excision system
2002 · Byung Jo Yu, Bong Hyun Sung, et al. · Nature Biotechnology · 144
TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin
2008 · Jong Gwang Kim, Sang Kyun Sohn, et al. · Cancer Chemotherapy and Pharmacology · 53
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety
2023 · Myongjae Lee, In-Gyu Je, et al. · Molecular Cancer Therapeutics · 17
PDF
A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics
2013 · Hye-Suk Han, Ki Hyeong Lee, et al. · Supportive Care in Cancer · 12
First‐In‐Human Dose Finding Study of Venadaparib ( IDX ‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors
2025 · Sung‐Bae Kim, Kyun‐Seop Bae, et al. · Cancer Medicine · 6
PDF
Prognostic Significance of Immunohistochemical Expression of p53 and Retinoblastoma Gene Protein (pRB) in Curatively Resected Gastric Cancer
2005 · Hong Suk Song, In Ho Kim, et al. · The Korean Journal of Internal Medicine · 6
PDF
Herpesviridae Viral Infections following Rituximab Combined Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma
2011 · Lee Chun Park, Ho Sup Lee, et al. · Acta Haematologica · 5
Co-mutation of ATM and ASXL1 and relationship to durable response of a novel PARP1/2 inhibitor, venadaparib, in patients with pancreatic cancer.
2023 · Keun Seok Lee, Woo Jin Lee, et al. · Journal of Clinical Oncology · 4
A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer
2007 · Sung Hwa Bae, Hun Mo Ryoo, et al. · Lung Cancer · 4
Anti-HER2/Neu Antibody Therapy Inhibits HER2 + Breast Cancer by Blocking Myeloid-Derived Suppressor Cell Activity
2025 · Jae-Hyeog Choi, Saegwang Park, et al. · Oncology Research and Treatment · 3
First-in-human dose-finding study of venadaparib (IDX-1197), a potent and selective PARP inhibitor, in patients with advanced solid tumors.
2021 · Yong Man Kim, Kyun-Seop Bae, et al. · Journal of Clinical Oncology · 3
A case of acinar cell carcinoma of the pancreas
2009 · Kyu Young Kim, Hwa Jung Lee, et al. · The Korean Journal of Internal Medicine · 3
Predictive role of homologous recombination deficiency (HRD) for irinotecan in combination with venadaparib, a novel PARP1/2 inhibitor, as third- or fourth-line treatment in patients with advanced gastric cancer.
2024 · Do-Youn Oh, Min-Hee Ryu, et al. · Journal of Clinical Oncology · 2
Efficacy of venadaparib plus irinotecan in homologous recombination deficiency (HRD) gene mutations as 3+ line treatment in patients with metastatic gastric cancer (mGC).
2025 · Won Sik Lee, Kyoung Soo Ha, et al. · Journal of Clinical Oncology · 1
Correction: Acute myeloid leukemia and myelodysplastic neoplasms: clinical implications of myelodysplasia‑related genes mutations and TP53 aberrations
2025 · Hyunwoo Kim, Ja Young Lee, et al. · Blood Research · 1
PDF
Association between homologous recombination deficiency (HRD) gene mutations and the efficacy of venadaparib in combination with irinotecan as third- or fourth-line treatment in patients with metastatic gastric cancer (mGC).
2024 · Min-Hee Ryu, Hyung-Don Kim, et al. · Journal of Clinical Oncology · 1
PDF
Quantification of venadaparib, a novel PARP inhibitor, in the rat and dog plasma using liquid chromatography/tandem mass spectrometry
2023 · Myongjae Lee, Eunhye Jang, et al. · Journal of Analytical Science & Technology · 1
PDF
Abstract CT234: VASTUS - a phase 1b/2a basket trial of a new PARP inhibitor, IDX-1197, including PARP inhibitor resistant cohort
2021 · Kyung-Hun Lee, Ahrum Min, et al. · Cancer Research · 1
A Case of Thyrotoxic Hypokalemic Periodic Paralysis Presenting as Cardiac Arrest.
2019 · Chang Ho Song, Choon Hee Chung, et al. · Journal of Korean Endocrine Society · 1
A case of micropapillary breast cancer with endometrial metastasis
2010 · Hwa Jeong Lee, Seong Hun Kang, et al. · The Korean Journal of Internal Medicine · 1
The Usefulness in an Automated Kinetic Method in Determining of ADA Activity in Pleural Fluid
1995 · Jeong Seon Ryu, Suk Joong Yong, et al. · Tuberculosis & respiratory diseases · 1
PDF
A Study of the Renin-Angiotensin System and the Blood Volume in the Nephrotic Syndrome
1986 · Ho Dae Yoo, Kwang Su Choi, et al. · The Korean Journal of Internal Medicine · 1
PDF
A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R‐ VRD ) in patients with Waldenström's macroglobulinaemia ( KMM1803 )
2025 · Sung‐Hoon Jung, Dajung Kim, et al. · British Journal of Haematology
Supplementary Data from Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety
2025 · Myongjae Lee, In-Gyu Je, et al.
Survival Benefits of Early Treatment With Blinatumomab in Adult Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
2025 · Dong Won Baek, Sang Kyun Sohn, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 40
Citation count: 271
H-index: 6
I10-index: 4
Year
Topic
Type